Search Results 2361-2370 of 14668 for anti-TNF drugs

  1. Trametinib (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  2. Diphtheria, Tetanus, Acellular Pertussis, Polio Vaccine (Intramuscular Route) Precautions - Mayo Clinic

    If your child has an infection due to diphtheria, tetanus, pertussis, or polio, your child will need medicines to treat these infections. Fainting may occur ...

  3. Belantamab Mafodotin-Blmf (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  4. Tesevatinib in Subjects With ADPKD - Mayo Clinic

    By condition, treatment or drug ... anti-estrogens, or ovarian suppression. Women of ... Subject is taking any medication known to inhibit the CYP3A4 isozyme or any ...

  5. Iga Nephropathy (Berger Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the effectiveness, safety and pharmacokinetic (PK)/pharmacodynamic (PD) relationship of the human anti-CD38 antibody ...

  6. Trastuzumab-Anns (Intravenous Route) Precautions - Mayo Clinic

    Receiving this medicine while you are pregnant can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant during treatment ...

  7. Remifentanil (Intravenous Route) Precautions - Mayo Clinic

    Some examples of medicines that affect the CNS are antihistamines or medicine for allergies or colds, sedatives, tranquilizers, or sleeping medicines, medicine ...

  8. Mayo Clinic in Arizona is the First in the Southwest to Offer New Treatment for Recurrent Glioblastoma Brain Tumors

    Mayo Clinic in Arizona is the First in the Southwest to Offer New Treatment for Recurrent Glioblastoma Brain Tumors. By. mayonewsreleases. November 8, 2012 ...

  9. Immuno-Epigenetics: William A. Faubion Jr.

    Faubion's lab seeks to discover, identify and develop individualized treatments to improve treatment options for people with inflammatory bowel disease (IBD).

  10. A Study of WVT078 in Patients With Multiple Myeloma - Mayo Clinic

    Use of systemic chronic steroid therapy (≥ 10mg/day prednisone or equivalent) or any immunosuppressive therapy within 7 days of first dose of study treatment.